As part of the rationalisation of its distributors network, Truscreen Limited (NZX: TRU) (“the Company”) is pleased to announce that it has appointed prominent medical…
Cervical cancer screening technology company TruScreen Limited (NZX:TRU) (the Company) has released its audited financial results for the year ended 31 March 2020.
Truscreen is pleased to announce that its previously announced offer to raise $1,000,000 through a priority allocation to an NZX market participant closed on 3…